Amgen Inc.
PEPTIDE PAC1 ANTAGONISTS
Last updated:
Abstract:
Novel peptides that bind to human PAC1 are provided. These peptides that are antagonists of PAC1 are useful in a number of PAC1 related disorders, including the treatment and/or prevention of headache disorders, including migraine, such as acute migraine.
Status:
Application
Type:
Utility
Filling date:
1 Jun 2018
Issue date:
23 Dec 2021